TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas

Miguel Melo; Adriana Gaspar da Rocha; João Vinagre; Rui Batısta; Joana Peixoto; Catarina Tavares; Ricardo Celestino; Ana Paula de Almeida; Catarina Salgado; Catarina Eloy; Patrícia Castro; Hugo Prazeres; Jorge Lima; Teresina Amaro; Cláudia Lobo; Maria João Martins; Margarida M. Moura; Branca Cavaco; Valeriano Leite; José Cameselle-Teijeiro; Francisco Carrilho; Manuela Carvalheiro; Valdemar Máximo; Manuel Sobrinho‐Simões; Paula Soares

doi:10.1210/jc.2013-3734

Abstract

TERT promoter mutations are an indicator of clinically aggressive tumors, being correlated with worse outcome and disease-specific mortality in DTC. TERT promoter mutations have an independent prognostic value in DTC and, notably, in PTC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Melo et al. (2014) studied this question.

synapsesocial.com/papers/69dd6f3a30fba8aacf40c681 https://doi.org/10.1210/jc.2013-3734

View Full Paper

Ask AI

Bookmark

Share

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas

Abstract

Discussion

Cite This Study

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas

Abstract

Discussion

Cite This Study

Keep reading

Keep reading